Mattia Boeri

Prognostic determinants in epithelioid sarcoma.

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer.

Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis.

Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study.

Assessment of circulating microRNAs in plasma of lung cancer patients.

Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know.

DRAGO (KIAA0247), a new DNA damage-responsive, p53-inducible gene that cooperates with p53 as oncosuppressor. [Corrected].

YAP1 acts as oncogenic target of 11q22 amplification in multiple cancer subtypes.

Therapeutic use of microRNAs in lung cancer.

Corrigendum to 'Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know'.

Potential biomarkers for lung cancer screening.

Recent advances of microRNA-based molecular diagnostics to reduce false-positive lung cancer imaging.

Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk Populations.

Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.

Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening Participants.

[Lung cancer screening in high-risk subjects: early detection with LDCT and risk stratification using miRNA-based blood test].

MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature.

Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers.

Inflammatory status and lung function predict mortality in lung cancer screening participants.

Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancer.

Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.